BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9724039)

  • 21. Ontogeny of 11beta-hydroxysteroid dehydrogenase: activity in the placenta, kidney, colon of fetal rats and rabbits.
    Hundertmark S; Bühler H; Fromm M; Kruner-Gareis B; Kruner M; Ragosch V; Kuhlmann K; Seckl JR
    Horm Metab Res; 2001 Feb; 33(2):78-83. PubMed ID: 11294497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal inactivation, mineralocorticoid generation, and 11beta-hydroxysteroid dehydrogenase inhibition ameliorate the antimineralocorticoid effect of progesterone in vivo.
    Quinkler M; Meyer B; Oelkers W; Diederich S
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3767-72. PubMed ID: 12915667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution of glucocorticoid and mineralocorticoid receptors and 11beta-hydroxysteroid dehydrogenases in human and rat ocular tissues.
    Stokes J; Noble J; Brett L; Phillips C; Seckl JR; O'Brien C; Andrew R
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1629-38. PubMed ID: 10845579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of rat renal and testicular 11 beta-hydroxysteroid dehydrogenase by some antihypertensive drugs, diuretics, and epitestosterone.
    Bicíková M; Hill M; Hampl R; Stárka L
    Horm Metab Res; 1997 Sep; 29(9):465-8. PubMed ID: 9370118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor necrosis factor alpha and interleukin 1beta enhance the cortisone/cortisol shuttle.
    Escher G; Galli I; Vishwanath BS; Frey BM; Frey FJ
    J Exp Med; 1997 Jul; 186(2):189-98. PubMed ID: 9221748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical investigation of 11 beta-hydroxysteroid dehydrogenase.
    Walker BR; Best R
    Endocr Res; 1995; 21(1-2):379-87. PubMed ID: 7588401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of 11 beta-hydroxysteroid dehydrogenase along the rabbit nephron.
    Bonvalet JP; Doignon I; Blot-Chabaud M; Pradelles P; Farman N
    J Clin Invest; 1990 Sep; 86(3):832-7. PubMed ID: 2394832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnolol from Magnolia officinalis inhibits 11beta-hydroxysteroid dehydrogenase without increases of corticosterone and thymocyte apoptosis in mice.
    Horigome H; Homma M; Hiran T; Oka K; Niitsuma T; Hayashi T
    Planta Med; 2001 Feb; 67(1):33-7. PubMed ID: 11270719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo effects of stress, ACTH and corticosterone on testicular 11beta-hydroxysteroid dehydrogenase oxidative activity in rats and the possible mechanism of actions.
    Nwe KH; Norhazlina AW; Hamid A; Morat PB; Khalid BA
    Exp Clin Endocrinol Diabetes; 2000; 108(5):369-77. PubMed ID: 10989957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension.
    Odermatt A; Dick B; Arnold P; Zaehner T; Plueschke V; Deregibus MN; Repetto H; Frey BM; Frey FJ; Ferrari P
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1247-52. PubMed ID: 11238516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of glycyrrhetinic acid derivatives on hepatic and renal 11beta-hydroxysteroid dehydrogenase activities in rats.
    Shimoyama Y; Hirabayashi K; Matsumoto H; Sato T; Shibata S; Inoue H
    J Pharm Pharmacol; 2003 Jun; 55(6):811-7. PubMed ID: 12841942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of 11beta-hydroxysteroid dehydrogenase in guinea pig kidney by three bioflavonoids and their interactions with gossypol.
    Wang MS; Shi H; Wang KS; Reidenberg MM
    Acta Pharmacol Sin; 2002 Jan; 23(1):92-6. PubMed ID: 11860745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of angiotensin-converting enzyme inhibition on renal adaptations to acute furosemide administration in conscious rats.
    Bak M; Shalmi M; Petersen JS; Poulsen LB; Christensen S
    J Pharmacol Exp Ther; 1993 Jul; 266(1):33-40. PubMed ID: 8392557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective inhibition of human type 1 11beta-hydroxysteroid dehydrogenase by synthetic steroids and xenobiotics.
    Hult M; Jörnvall H; Oppermann UC
    FEBS Lett; 1998 Dec; 441(1):25-8. PubMed ID: 9877158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of 11 beta-hydroxysteroid dehydrogenase obtained from guinea pig kidney by furosemide, naringenin and some other compounds.
    Zhang YD; Lorenzo B; Reidenberg MM
    J Steroid Biochem Mol Biol; 1994 May; 49(1):81-5. PubMed ID: 8003443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel effects of deoxycorticosterone on testicular 11beta-hydroxysteroid dehydrogenase activity and plasma testosterone levels in normal and adrenalectomized rats.
    Nwe KH; Morat PB; Hamid A; Fadzilah S; Khalid BA
    Exp Clin Endocrinol Diabetes; 1999; 107(5):288-94. PubMed ID: 10482040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Administration of glycyrrhetinic acid: significant correlation between serum levels and the cortisol/cortisone-ratio in serum and urine.
    Heilmann P; Heide J; Hundertmark S; Schöneshöfer M
    Exp Clin Endocrinol Diabetes; 1999; 107(6):370-8. PubMed ID: 10543414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Local modulation by 11beta-hydroxysteroid dehydrogenase of glucocorticoid effects on the activity of 15-hydroxyprostaglandin dehydrogenase in human chorion and placental trophoblast cells.
    Patel FA; Sun K; Challis JR
    J Clin Endocrinol Metab; 1999 Feb; 84(2):395-400. PubMed ID: 10022390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 11 beta-Hydroxysteroid dehydrogenase type 2 complementary deoxyribonucleic acid stably transfected into Chinese hamster ovary cells: specific inhibition by 11 alpha-hydroxyprogesterone.
    Morita H; Zhou M; Foecking MF; Gomez-Sanchez EP; Cozza EN; Gomez-Sanchez CE
    Endocrinology; 1996 Jun; 137(6):2308-14. PubMed ID: 8641180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 11beta-Hydroxysteroid dehydrogenase type 2 in the rat corpus luteum: induction of messenger ribonucleic acid expression and bioactivity coincident with luteal regression.
    Waddell BJ; Benediktsson R; Seckl JR
    Endocrinology; 1996 Dec; 137(12):5386-91. PubMed ID: 8940361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.